Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge

Pfizer’s $43 Billion Seagen Takeover Faces FTC Scrutiny

FTC Chief Lina Khan’s Bad Week Dims Hopes for New Era of Tech Antitrust

Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever

FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics